Simms Christopher Paul
SEC insider (Form 3/4/5 filer). CIK 0001877012. Officer at 4D Molecular Therapeutics, Inc. (FDMT). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 25, 2026. Located in EMERYVILLE, CA.
Companies Simms Christopher Paul has filed insider reports for
- 4D Molecular Therapeutics, Inc. (FDMT): Officer, See Remarks
Simms Christopher Paul
CIK: 0001877012
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FDMT
4D Molecular Therapeutics, Inc.
Officer